Evidence map›Paper›PMID 28550191›Full record

ArticleHaematologica2017

The level of deletion 17p and bi-allelic inactivation of

Sharmilan Thanendrarajan, Erming Tian, Pingping Qu, Pankaj Mathur, Carolina Schinke, Frits van Rhee, Maurizio Zangari, Leo Rasche, Niels Weinhold, Daisy Alapat and 11 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. [Prognostic value of high-risk cytogenetic abnormalities inmultiple myeloma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Recent Advances in The Definition of the Molecular Alterations Occurring in Multiple Myeloma.Mediterranean journal of hematology and infectious diseases · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sharmilan ThanendrarajanMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Erming TianMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Pingping QuMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Pankaj MathurMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Carolina SchinkeMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Frits van RheeMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Maurizio ZangariMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Leo RascheMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Niels WeinholdMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Daisy AlapatDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
William BellamyDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Cody AshbyMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Sandra MattoxMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Joshua EpsteinMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Shmuel YaccobyMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Bart BarlogieMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Antje HoeringCancer Research and Biostatistics, Seattle, WA, USA.
Michael BauerMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Brian A WalkerMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Faith E DaviesMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Gareth J MorganMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA gjmorgan@uams.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 17AgedAged, 80 and overHumansMultiple MyelomaSurvival AnalysisTreatment OutcomeTumor Suppressor Protein p53TP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID28550191
PMCPMC5685226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.